Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Stratasys
SSYS
$772M
| $3.24M | ﹤0.01% |
279,225
+8,808
| +3% | +$113K |
|
|
MLNK
2452
DELISTED
MeridianLink
MLNK
| $3.24M | ﹤0.01% |
173,176
+86
| +0% | +$1.75K |
|
2453
Advantage Solutions
ADV
$541M
| $3.23M | ﹤0.01% |
29,805
+346
| +1% | +$34K |
|
2454
Cerus
CERS
$427M
| $3.23M | ﹤0.01% |
1,706,492
+49,836
| +3% | +$102K |
|
2455
FRP Holdings
FRPH
$429M
| $3.22M | ﹤0.01% |
104,836
+928
| +0.9% | +$27.8K |
|
2456
Bally's
BALY
$670M
| $3.21M | ﹤0.01% |
230,070
+2,428
| +1% | +$28.3K |
|
2457
Anavex Life Sciences
AVXL
$303M
| $3.21M | ﹤0.01% |
630,067
+7,757
| +1% | +$43.7K |
|
|
FARO
2458
DELISTED
Faro Technologies
FARO
| $3.19M | ﹤0.01% |
148,495
+1,498
| +1% | +$32.5K |
|
|
INST
2459
DELISTED
Instructure Holdings, Inc.
INST
| $3.17M | ﹤0.01% |
148,074
+1,716
| +1% | +$40.4K |
|
2460
The RMR Group
RMR
$325M
| $3.15M | ﹤0.01% |
131,228
-107,990
| -45% | -$2.71M |
|
2461
Definitive Healthcare
DH
$71.8M
| $3.15M | ﹤0.01% |
390,136
+4,864
| +1% | +$43K |
|
2462
GoodRx Holdings
GDRX
$1.08B
| $3.12M | ﹤0.01% |
438,862
+565
| +0.1% | +$3.74K |
|
2463
Blend Labs
BLND
$482M
| $3.11M | ﹤0.01% |
957,774
+53,435
| +6% | +$144K |
|
2464
Xponential Fitness
XPOF
$279M
| $3.11M | ﹤0.01% |
188,162
-3,011
| -2% | -$37K |
|
2465
Evolv Technologies
EVLV
$1.08B
| $3.11M | ﹤0.01% |
699,242
+6,209
| +0.9% | +$26.8K |
|
2466
Clearfield
CLFD
$462M
| $3.1M | ﹤0.01% |
100,473
+789
| +0.8% | +$22.6K |
|
2467
Alerus Financial
ALRS
$855M
| $3.09M | ﹤0.01% |
141,554
+3,346
| +2% | +$73.4K |
|
2468
Vivid Seats
SEAT
$96.2M
| $3.08M | ﹤0.01% |
25,670
+8,556
| +50% | +$1M |
|
|
AGTI
2469
DELISTED
Agiliti Inc
AGTI
| $3.07M | ﹤0.01% |
303,636
+12,918
| +4% | +$108K |
|
2470
Digimarc Corp
DMRC
$166M
| $3.07M | ﹤0.01% |
112,820
+3,434
| +3% | +$119K |
|
|
FFWM
2471
DELISTED
First Foundation Inc
FFWM
| $3.05M | ﹤0.01% |
404,385
+6,257
| +2% | +$53.5K |
|
2472
DMC Global
BOOM
$149M
| $3.05M | ﹤0.01% |
156,342
+5,812
| +4% | +$102K |
|
2473
Heron Therapeutics
HRTX
$101M
| $3.02M | ﹤0.01% |
1,091,138
+93,937
| +9% | +$236K |
|
2474
Build-A-Bear
BBW
$426M
| $3.02M | ﹤0.01% |
101,054
+8,457
| +9% | +$203K |
|
2475
Tango Therapeutics
TNGX
$4.71B
| $3.01M | ﹤0.01% |
379,477
+10,411
| +3% | +$112K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.